Starpharma
  • About Us
  • Technology
  • VIRALEZE
  • VivaGel®
  • DEP® Drug Delivery
  • News
  • Investor Centre
    • 2020 Annual General Meeting
    • ASX Announcements
    • News Archive
    • Update Shareholder Information
    • Financial Reports
    • Analyst Coverage
    • Shareholder Updates
    • Corporate Governance
    • Email Alerts
    • Share Price History
  • Contact Us
  1. Starpharma
  2. Home
  3. Investor Centre
  4. News Archive

News Archive

2021 2020 2019 2018 2017 2016

Feb 2021

Feb 25, 2021 Interim Report and Half-Year Financial Results

Feb 23, 2021 Channel 7 News reports Starpharma's VIRALEZE has been registered in the UK/Europe

Feb 23, 2021 VIRALEZE™ antiviral nasal spray registered in Europe

Feb 12, 2021 Starpharma signs research agreement with MSD

Feb 12, 2021 Starpharma signs DEP® ADC Research Agreement with MSD

Feb 10, 2021 Ausbiz interviews Starpharma CEO Dr Jackie Fairley

Feb 09, 2021 AZD0466 clinical DEP® program global expansion

Feb 04, 2021 Aussie condom antiviral recruited for Covid-19 fight

Feb 04, 2021 Australian-developed COVID nasal spray set to land in Europe

Feb 03, 2021 Channel 7 evening news features Starpharma's VIRALEZE

Feb 02, 2021 Starpharma prepares to launch COVID-killing nasal spray

Jan 2021

Jan 29, 2021 Quarterly Cashflow and Activity Report

Jan 09, 2021 Leading broker names the ASX healthcare shares to buy in 2021

2021 2020 2019 2018 2017 2016

 

Online_News.jpg

© Starpharma Holdings Limited 2020
  • Sitemap
  • Privacy
  • Media
  • Disclaimer